Search:


Media Contact
Annette Ballou
Email
216.658.3999
Newsroom > News
print
ViewRay, a Cleveland-based developer of the Renaissance™ System 1000, combining MRI and gamma ray radiotherapy for the treatment of cancer, has secured $10.3 million from existing investors - Orbimed, Fidelity BioSciences, Kearny Venture Partners, Ailsing Capital and Siemens Venture Capital.

Click here to read more from Xconomy, Inc.
Recent News

»  Great Lakes NeuroTechnologies Receives $4.5 Million

»  Life Core Technologies Raises Seed Funding

»  Research Organics acquired by Sigma-Aldrich

»  CardioInsight Raises $7.5 Million

»  ViewRay Raises $16 Million




The 2012 Venture Report

Cleveland:
Health Care Innovation Destination

» View / Download






Sign Up for BioEnterprise eNews

Add me to your emailing list: sign up




Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the health care industry.
» View More
 
Copyright © 2012 BioEnterprise   | Home | Disclaimer | Sitemap | Contact Us BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999